Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
In December 2019, a severe outbreak of a novel coronavirus (COVID-19) occurred in the whole world, posing a great threat to people's health. With the outbreak and development of the epidemic, how to improve the cure rate, find effective drugs against this virus, has been the most urgent problem...
Saved in:
Main Authors: | Yan Chen (Author), TaiPeng Shen (Author), LiJun Zhong (Author), ZhiXi Liu (Author), XinWei Dong (Author), TingWenLi Huang (Author), QiuJu Wang (Author), HongTao Xiao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia
by: Yan Chen, et al.
Published: (2020) -
Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
by: Lu Huang, et al.
Published: (2022) -
Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020) -
Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
by: Javad Mahmoudi, et al.
Published: (2021) -
Chloroquine and Hydroxychloroquine: Potentially Inappropriate Medications for Older Adults?
by: Milton Gorzoni
Published: (2024)